$CNFN
CFN Enterprises Inc.

2017 Q2 Form 10-Q Financial Statement

#000143774917014706 Filed on August 14, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q2
Revenue $5.994M $6.003M
YoY Change -0.15% 9.83%
Cost Of Revenue $2.365M $2.031M
YoY Change 16.48% 27.61%
Gross Profit $3.629M $3.973M
YoY Change -8.65% 2.53%
Gross Profit Margin 60.54% 66.17%
Selling, General & Admin $1.752M $2.247M
YoY Change -22.05% -4.43%
% of Gross Profit 48.27% 56.57%
Research & Development $1.133M $974.0K
YoY Change 16.37% -26.57%
% of Gross Profit 31.23% 24.52%
Depreciation & Amortization $34.08K $96.75K
YoY Change -64.78% 15.18%
% of Gross Profit 0.94% 2.44%
Operating Expenses $3.968M $4.096M
YoY Change -3.11% -26.77%
Operating Profit -$339.6K -$123.1K
YoY Change 175.99% -92.84%
Interest Expense -$280.0K -$210.0K
YoY Change 33.33% 425.0%
% of Operating Profit
Other Income/Expense, Net -$277.1K -$210.2K
YoY Change 31.82% 406.45%
Pretax Income -$620.0K -$330.0K
YoY Change 87.88% -81.25%
Income Tax
% Of Pretax Income
Net Earnings -$616.7K -$333.3K
YoY Change 85.05% -81.06%
Net Earnings / Revenue -10.29% -5.55%
Basic Earnings Per Share -$0.01 -$0.01
Diluted Earnings Per Share -$0.01 -$0.01
COMMON SHARES
Basic Shares Outstanding 65.28M 65.07M
Diluted Shares Outstanding 65.28M 65.07M

Balance Sheet

Concept 2017 Q2 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $120.0K $880.0K
YoY Change -86.36% 120.0%
Cash & Equivalents $120.4K $879.7K
Short-Term Investments
Other Short-Term Assets $810.0K $990.0K
YoY Change -18.18% 147.5%
Inventory
Prepaid Expenses
Receivables $2.182M $1.992M
Other Receivables $0.00 $0.00
Total Short-Term Assets $3.116M $3.857M
YoY Change -19.2% 24.69%
LONG-TERM ASSETS
Property, Plant & Equipment $3.473M $2.447M
YoY Change 41.94% 68.7%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $106.2K $110.3K
YoY Change -3.74% -18.04%
Total Long-Term Assets $3.579M $2.557M
YoY Change 39.97% 55.45%
TOTAL ASSETS
Total Short-Term Assets $3.116M $3.857M
Total Long-Term Assets $3.579M $2.557M
Total Assets $6.695M $6.414M
YoY Change 4.39% 35.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.120M $1.870M
YoY Change 13.37% 10.65%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $380.0K $590.0K
YoY Change -35.59%
Long-Term Debt Due $2.480M $0.00
YoY Change
Total Short-Term Liabilities $5.075M $2.462M
YoY Change 106.08% 40.78%
LONG-TERM LIABILITIES
Long-Term Debt $4.490M $5.490M
YoY Change -18.21% 22.0%
Other Long-Term Liabilities $1.275M
YoY Change
Total Long-Term Liabilities $1.275M $5.490M
YoY Change -76.78% 22.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.075M $2.462M
Total Long-Term Liabilities $1.275M $5.490M
Total Liabilities $10.83M $7.947M
YoY Change 36.33% 27.18%
SHAREHOLDERS EQUITY
Retained Earnings -$29.79M -$26.18M
YoY Change 13.78% 17.12%
Common Stock $65.28K $65.06K
YoY Change 0.34% 3.54%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$4.140M -$1.534M
YoY Change
Total Liabilities & Shareholders Equity $6.695M $6.414M
YoY Change 4.39% 35.37%

Cashflow Statement

Concept 2017 Q2 2016 Q2
OPERATING ACTIVITIES
Net Income -$616.7K -$333.3K
YoY Change 85.05% -81.06%
Depreciation, Depletion And Amortization $34.08K $96.75K
YoY Change -64.78% 15.18%
Cash From Operating Activities -$110.0K -$770.0K
YoY Change -85.71% -46.53%
INVESTING ACTIVITIES
Capital Expenditures -$20.00K -$10.00K
YoY Change 100.0% -87.5%
Acquisitions
YoY Change
Other Investing Activities -$380.0K -$550.0K
YoY Change -30.91% 189.47%
Cash From Investing Activities -$400.0K -$560.0K
YoY Change -28.57% 115.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 110.0K 1.160M
YoY Change -90.52% 93.33%
NET CHANGE
Cash From Operating Activities -110.0K -770.0K
Cash From Investing Activities -400.0K -560.0K
Cash From Financing Activities 110.0K 1.160M
Net Change In Cash -400.0K -170.0K
YoY Change 135.29% -84.55%
FREE CASH FLOW
Cash From Operating Activities -$110.0K -$770.0K
Capital Expenditures -$20.00K -$10.00K
Free Cash Flow -$90.00K -$760.0K
YoY Change -88.16% -44.12%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
aclz Cashless Exercise Of Options
CashlessExerciseOfOptions
2400000
CY2016Q4 aclz Common Stock Issued And Outstanding Percentage Decrease
CommonStockIssuedAndOutstandingPercentageDecrease
0.03
aclz Fair Value Of Options And Warrants
FairValueOfOptionsAndWarrants
433404
aclz Fair Value Of Options And Warrants
FairValueOfOptionsAndWarrants
803383
aclz Fair Value Of Warrants Issued In Connection With Line Of Credit
FairValueOfWarrantsIssuedInConnectionWithLineOfCredit
aclz Fair Value Of Warrants Issued In Connection With Line Of Credit
FairValueOfWarrantsIssuedInConnectionWithLineOfCredit
391618
aclz Noncash Expenses Paid On Companys Behalf
NoncashExpensesPaidOnCompanysBehalf
aclz Noncash Expenses Paid On Companys Behalf
NoncashExpensesPaidOnCompanysBehalf
204920
CY2017Q2 aclz Other Finance Fees
OtherFinanceFees
24125
CY2016Q2 aclz Other Finance Fees
OtherFinanceFees
22200
aclz Other Finance Fees
OtherFinanceFees
48250
aclz Other Finance Fees
OtherFinanceFees
158355
aclz Repayment Of Line Of Credit Noncash Investing And Financing Activities
RepaymentOfLineOfCreditNoncashInvestingAndFinancingActivities
aclz Repayment Of Line Of Credit Noncash Investing And Financing Activities
RepaymentOfLineOfCreditNoncashInvestingAndFinancingActivities
4572223
aclz Repayment Of Loan Noncash Investing And Financing Activities
RepaymentOfLoanNoncashInvestingAndFinancingActivities
25000
aclz Repayment Of Loan Noncash Investing And Financing Activities
RepaymentOfLoanNoncashInvestingAndFinancingActivities
25000
aclz Stock Issued During Period Shares Stock Options Exercised Noncash
StockIssuedDuringPeriodSharesStockOptionsExercisedNoncash
1707692
CY2017Q2 aclz Weighted Average Number Of Diluted Shares Outstanding Discontinued Operations
WeightedAverageNumberOfDilutedSharesOutstandingDiscontinuedOperations
65283042
CY2016Q2 aclz Weighted Average Number Of Diluted Shares Outstanding Discontinued Operations
WeightedAverageNumberOfDilutedSharesOutstandingDiscontinuedOperations
65069327
aclz Weighted Average Number Of Diluted Shares Outstanding Discontinued Operations
WeightedAverageNumberOfDilutedSharesOutstandingDiscontinuedOperations
65272723
aclz Weighted Average Number Of Diluted Shares Outstanding Discontinued Operations
WeightedAverageNumberOfDilutedSharesOutstandingDiscontinuedOperations
65069327
CY2017Q2 aclz Weightedaverage Antidilutive Securities Excluded From Computation Of Earnings Per Share Amountloss
WeightedaverageAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountloss
16361556
CY2016Q2 aclz Weightedaverage Antidilutive Securities Excluded From Computation Of Earnings Per Share Amountloss
WeightedaverageAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountloss
18551891
aclz Weightedaverage Antidilutive Securities Excluded From Computation Of Earnings Per Share Amountloss
WeightedaverageAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountloss
16318872
aclz Weightedaverage Antidilutive Securities Excluded From Computation Of Earnings Per Share Amountloss
WeightedaverageAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountloss
18710764
CY2017Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2124906
CY2016Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2639008
CY2017Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2182431
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2229610
CY2017Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2969504
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2585072
CY2017Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-58072
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-77329
CY2017Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
25643273
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
25211737
us-gaap Advertising Cost Policy Expensed Advertising Cost
AdvertisingCostPolicyExpensedAdvertisingCost
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; text-decoration: underline;">Advertising</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company expenses advertising costs as incurred.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 95%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="6"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Three months ended </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 30pt" colspan="6"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 7.5pt 0pt 30pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Six months ended</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="6"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">June 30,</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 30pt" colspan="6"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 7.5pt 0pt 30pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">June 30,</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2017</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2017</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px">&nbsp;</td> </tr> <tr> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Advertising expense</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">83,728</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">39,351</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">170,755</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">76,677</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div></div></div></div></div>
CY2017Q2 us-gaap Advertising Expense
AdvertisingExpense
83728
CY2016Q2 us-gaap Advertising Expense
AdvertisingExpense
39351
us-gaap Advertising Expense
AdvertisingExpense
170755
us-gaap Advertising Expense
AdvertisingExpense
76677
CY2017Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
125867
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
251734
CY2016Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
270508
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
554601
CY2017Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
366746
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
349535
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
115644
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
75798
CY2017Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
55837
CY2016Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
62432
CY2017Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
181531
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
315103
CY2016Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
186219
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
375579
CY2017Q2 us-gaap Assets
Assets
6695323
CY2016Q4 us-gaap Assets
Assets
7393624
CY2017Q2 us-gaap Assets Current
AssetsCurrent
3116372
CY2016Q4 us-gaap Assets Current
AssetsCurrent
4357924
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
7282
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
CY2017Q2 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
3360000
CY2016Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
2784000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1680127
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
908095
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
120422
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
879666
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1559705
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-28429
CY2017Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-601532
CY2016Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-355574
CY2017Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
65283042
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
63415254
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
63415254
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
65283042
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
63415254
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
65282
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
63414
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-652676
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-946003
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; text-decoration: underline;">Concentration of Credit Risks</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company is subject to concentrations of credit risk primarily from cash and cash equivalents and accounts receivable.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company&#x2019;s cash and cash equivalents accounts are held at a financial institution and are insured by the Federal Deposit Insurance Corporation, or the FDIC, up to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$250,000.</div> During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div>-month period ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2017, </div>the Company has reached bank balances exceeding the FDIC insurance limit. To reduce its risk associated with the failure of such financial institutions, the Company periodically evaluates the credit quality of the financial institution in which it holds deposits.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company's accounts receivable are due from customers, generally located in the United States, Europe, Asia, and Canada. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">None</div> of the Company&#x2019;s customers accounted for more than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of its accounts receivable at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2017 </div>or <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016.&nbsp;&nbsp;</div>The Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> require any collateral from its customers.</div></div></div></div></div></div>
CY2017Q2 us-gaap Cost Of Revenue
CostOfRevenue
2365364
CY2016Q2 us-gaap Cost Of Revenue
CostOfRevenue
2030687
us-gaap Cost Of Revenue
CostOfRevenue
3910709
us-gaap Cost Of Revenue
CostOfRevenue
3962810
CY2017Q2 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
19582
CY2016Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
43133
CY2017Q2 us-gaap Deferred Revenue
DeferredRevenue
91217
CY2016Q4 us-gaap Deferred Revenue
DeferredRevenue
53450
CY2017Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
91217
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
53450
CY2017Q2 us-gaap Depreciation
Depreciation
34075
CY2016Q2 us-gaap Depreciation
Depreciation
96749
us-gaap Depreciation
Depreciation
69530
us-gaap Depreciation
Depreciation
174062
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
384633
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
549641
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
19257
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-29497
CY2017Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
323867
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y90D
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-902
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
448
CY2016 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
2200000
CY2017Q2 us-gaap Gross Profit
GrossProfit
3628790
us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
500000
CY2017Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
278129
CY2016Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
221683
us-gaap Interest Expense Debt
InterestExpenseDebt
558581
us-gaap Interest Expense Debt
InterestExpenseDebt
434232
CY2016Q2 us-gaap Gross Profit
GrossProfit
3972600
us-gaap Gross Profit
GrossProfit
8040169
us-gaap Gross Profit
GrossProfit
7904495
us-gaap Income Taxes Paid
IncomeTaxesPaid
0
us-gaap Income Taxes Paid
IncomeTaxesPaid
0
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-753229
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-365461
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-29968
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
153622
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
37767
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-7500
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3582
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-8076
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
365332
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
245521
us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
CY2017Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
198955
CY2016Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
126623
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
395545
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
194026
us-gaap Interest Paid
InterestPaid
395545
us-gaap Interest Paid
InterestPaid
419802
CY2017Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1042
CY2016Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
11475
us-gaap Investment Income Interest
InvestmentIncomeInterest
742
us-gaap Investment Income Interest
InvestmentIncomeInterest
20934
CY2017Q2 us-gaap Liabilities
Liabilities
10834969
CY2016Q4 us-gaap Liabilities
Liabilities
11313998
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6695323
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7393624
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5074536
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5238271
CY2014Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
6000000
CY2014Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
3000000
CY2017Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2477995
CY2016Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2038946
CY2017Q2 us-gaap Litigation Reserve
LitigationReserve
1700000
CY2017Q2 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
4485433
CY2016Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
4588227
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
119163
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1585650
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-923578
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1032399
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-774547
CY2016Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-552183
us-gaap Net Income Loss
NetIncomeLoss
-671933
us-gaap Net Income Loss
NetIncomeLoss
-916506
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-616709
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-333265
CY2017Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-616709
CY2016Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-333265
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-671933
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-916506
CY2017Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-277087
CY2016Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-210208
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-557839
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-413298
CY2017Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
3968412
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
4095657
us-gaap Operating Expenses
OperatingExpenses
8154263
us-gaap Operating Expenses
OperatingExpenses
8407703
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-339622
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-123057
us-gaap Operating Income Loss
OperatingIncomeLoss
-114094
us-gaap Operating Income Loss
OperatingIncomeLoss
-503208
CY2017Q2 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
380418
CY2016Q4 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
506867
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
17211
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-4943
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
129678
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
32980
CY2017Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
106157
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
102574
CY2017Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
15177
CY2016Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-22309
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
19257
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-29497
CY2017Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
15177
CY2016Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-22309
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
19257
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-29497
CY2017Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
15177
CY2016Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-22309
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
19257
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-29497
CY2017Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1275000
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1487500
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7585
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
891393
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1030456
CY2017Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
763519
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
398187
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
1150000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
1803105
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
795
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
5642
CY2017Q2 us-gaap Profit Loss
ProfitLoss
-616709
CY2016Q2 us-gaap Profit Loss
ProfitLoss
-333265
us-gaap Profit Loss
ProfitLoss
-671933
us-gaap Profit Loss
ProfitLoss
-916506
CY2017Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6442298
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5518198
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3472794
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2933126
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
1030837
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
87777
CY2017Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1133437
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
973980
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2176556
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2004436
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-29118196
CY2017Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
50000
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
50000
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-29790129
CY2017Q2 us-gaap Revenues
Revenues
5994154
CY2016Q2 us-gaap Revenues
Revenues
6003287
us-gaap Revenues
Revenues
11950878
us-gaap Revenues
Revenues
11867305
CY2017Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1083303
CY2016Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
874422
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2299793
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1867300
CY2017Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1751672
CY2016Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2247255
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3677914
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4535967
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
120000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2020000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.50
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10450000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
13125000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.43
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.38
us-gaap Stock Issued1
StockIssued1
1868
us-gaap Stock Issued1
StockIssued1
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
-4139646
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
-3920374
us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; text-decoration: underline;">Use of Estimates</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The preparation of unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reporting amounts of revenues and expenses during the reported period. Actual results will differ from those estimates. Included in these estimates are assumptions about collection of accounts receivable, useful life of fixed assets and intangible assets, and assumptions used in Black-Scholes-Merton, or BSM, valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate.</div></div></div></div></div></div>
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65283042
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65069327
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65272723
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65069327
CY2017Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
65283042
CY2016Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
65069327
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
65272723
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
65069327
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65283042
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65069327
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65272723
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65069327

Files In Submission

Name View Source Status
0001437749-17-014706-index-headers.html Edgar Link pending
0001437749-17-014706-index.html Edgar Link pending
0001437749-17-014706.txt Edgar Link pending
0001437749-17-014706-xbrl.zip Edgar Link pending
aclz-20170630.xml Edgar Link completed
aclz-20170630.xsd Edgar Link pending
aclz-20170630_cal.xml Edgar Link unprocessable
aclz-20170630_def.xml Edgar Link unprocessable
aclz-20170630_lab.xml Edgar Link unprocessable
aclz-20170630_pre.xml Edgar Link unprocessable
aclz20170630_10q.htm Edgar Link pending
ex10-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending